480 related articles for article (PubMed ID: 28948865)
21. Molecular modeling study on the allosteric inhibition mechanism of HIV-1 integrase by LEDGF/p75 binding site inhibitors.
Xue W; Liu H; Yao X
PLoS One; 2014; 9(3):e90799. PubMed ID: 24599328
[TBL] [Abstract][Full Text] [Related]
22. Characterization of the HIV-1 integrase chromatin- and LEDGF/p75-binding abilities by mutagenic analysis within the catalytic core domain of integrase.
Zheng Y; Ao Z; Jayappa KD; Yao X
Virol J; 2010 Mar; 7():68. PubMed ID: 20331877
[TBL] [Abstract][Full Text] [Related]
23. A New Class of Allosteric HIV-1 Integrase Inhibitors Identified by Crystallographic Fragment Screening of the Catalytic Core Domain.
Patel D; Antwi J; Koneru PC; Serrao E; Forli S; Kessl JJ; Feng L; Deng N; Levy RM; Fuchs JR; Olson AJ; Engelman AN; Bauman JD; Kvaratskhelia M; Arnold E
J Biol Chem; 2016 Nov; 291(45):23569-23577. PubMed ID: 27645997
[TBL] [Abstract][Full Text] [Related]
24. Identification of small peptides inhibiting the integrase-LEDGF/p75 interaction through targeting the cellular co-factor.
Cavalluzzo C; Christ F; Voet A; Sharma A; Singh BK; Zhang KY; Lescrinier E; De Maeyer M; Debyser Z; Van der Eycken E
J Pept Sci; 2013 Oct; 19(10):651-8. PubMed ID: 24014475
[TBL] [Abstract][Full Text] [Related]
25. Peptides derived from the HIV-1 integrase promote HIV-1 infection and multi-integration of viral cDNA in LEDGF/p75-knockdown cells.
Levin A; Hayouka Z; Friedler A; Loyter A
Virol J; 2010 Aug; 7():177. PubMed ID: 20678206
[TBL] [Abstract][Full Text] [Related]
26. Host factors for retroviral integration site selection.
Debyser Z; Christ F; De Rijck J; Gijsbers R
Trends Biochem Sci; 2015 Feb; 40(2):108-16. PubMed ID: 25555456
[TBL] [Abstract][Full Text] [Related]
27. The Structure-Specific Recognition Protein 1 Associates with Lens Epithelium-Derived Growth Factor Proteins and Modulates HIV-1 Replication.
Lopez AP; Kugelman JR; Garcia-Rivera J; Urias E; Salinas SA; Fernandez-Zapico ME; Llano M
J Mol Biol; 2016 Jul; 428(14):2814-31. PubMed ID: 27216501
[TBL] [Abstract][Full Text] [Related]
28. Impact of LEDGIN treatment during virus production on residual HIV-1 transcription.
Vansant G; Vranckx LS; Zurnic I; Van Looveren D; Van de Velde P; Nobles C; Gijsbers R; Christ F; Debyser Z
Retrovirology; 2019 Apr; 16(1):8. PubMed ID: 30940165
[TBL] [Abstract][Full Text] [Related]
29. Characterization of rare lens epithelium-derived growth factor/p75 genetic variants identified in HIV-1 long-term nonprogressors.
Schrijvers R; Demeulemeester J; De Rijck J; Christ F; Gérard M; Debyser Z; Gijsbers R
AIDS; 2013 Feb; 27(4):539-43. PubMed ID: 23211777
[TBL] [Abstract][Full Text] [Related]
30. The Competitive Interplay between Allosteric HIV-1 Integrase Inhibitor BI/D and LEDGF/p75 during the Early Stage of HIV-1 Replication Adversely Affects Inhibitor Potency.
Feng L; Dharmarajan V; Serrao E; Hoyte A; Larue RC; Slaughter A; Sharma A; Plumb MR; Kessl JJ; Fuchs JR; Bushman FD; Engelman AN; Griffin PR; Kvaratskhelia M
ACS Chem Biol; 2016 May; 11(5):1313-21. PubMed ID: 26910179
[TBL] [Abstract][Full Text] [Related]
31. Zinc finger endonuclease targeting PSIP1 inhibits HIV-1 integration.
Badia R; Pauls E; Riveira-Munoz E; Clotet B; Esté JA; Ballana E
Antimicrob Agents Chemother; 2014 Aug; 58(8):4318-27. PubMed ID: 24820090
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of a flavonoid library for inhibition of interaction of HIV-1 integrase with human LEDGF/p75 towards a structure-activity relationship.
Yin ZH; Yan HL; Pan Y; Zhang DW; Yan X
Ann Med; 2022 Dec; 54(1):1590-1600. PubMed ID: 35658757
[No Abstract] [Full Text] [Related]
33. LEDGIN-mediated Inhibition of Integrase-LEDGF/p75 Interaction Reduces Reactivation of Residual Latent HIV.
Vranckx LS; Demeulemeester J; Saleh S; Boll A; Vansant G; Schrijvers R; Weydert C; Battivelli E; Verdin E; Cereseto A; Christ F; Gijsbers R; Debyser Z
EBioMedicine; 2016 Jun; 8():248-264. PubMed ID: 27428435
[TBL] [Abstract][Full Text] [Related]
34. Rational design of LEDGINs as first allosteric integrase inhibitors for the treatment of HIV infection.
Desimmie BA; Demeulemeester J; Christ F; Debyser Z
Drug Discov Today Technol; 2013 Dec; 10(4):e517-22. PubMed ID: 24451643
[TBL] [Abstract][Full Text] [Related]
35. Insights into the interactions between HIV-1 integrase and human LEDGF/p75 by molecular dynamics simulation and free energy calculation.
Zhao Y; Li W; Zeng J; Liu G; Tang Y
Proteins; 2008 Aug; 72(2):635-45. PubMed ID: 18247352
[TBL] [Abstract][Full Text] [Related]
36. Differential interaction of HIV-1 integrase and JPO2 with the C terminus of LEDGF/p75.
Bartholomeeusen K; De Rijck J; Busschots K; Desender L; Gijsbers R; Emiliani S; Benarous R; Debyser Z; Christ F
J Mol Biol; 2007 Sep; 372(2):407-21. PubMed ID: 17669426
[TBL] [Abstract][Full Text] [Related]
37. Computational studies of the interaction between the HIV-1 integrase tetramer and the cofactor LEDGF/p75: insights from molecular dynamics simulations and the informational spectrum method.
Tintori C; Veljkovic N; Veljkovic V; Botta M
Proteins; 2010 Dec; 78(16):3396-408. PubMed ID: 20878714
[TBL] [Abstract][Full Text] [Related]
38. Discovery of novel 3-hydroxypicolinamides as selective inhibitors of HIV-1 integrase-LEDGF/p75 interaction.
Zhang FH; Debnath B; Xu ZL; Yang LM; Song LR; Zheng YT; Neamati N; Long YQ
Eur J Med Chem; 2017 Jan; 125():1051-1063. PubMed ID: 27810592
[TBL] [Abstract][Full Text] [Related]
39. Overexpression of the lens epithelium-derived growth factor/p75 integrase binding domain inhibits human immunodeficiency virus replication.
De Rijck J; Vandekerckhove L; Gijsbers R; Hombrouck A; Hendrix J; Vercammen J; Engelborghs Y; Christ F; Debyser Z
J Virol; 2006 Dec; 80(23):11498-509. PubMed ID: 16987986
[TBL] [Abstract][Full Text] [Related]
40. Structural basis for the potent inhibition of the HIV integrase-LEDGF/p75 protein-protein interaction.
Ribone SR; Quevedo MA
J Mol Graph Model; 2017 Aug; 75():189-198. PubMed ID: 28582696
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]